Oral Delivery of Bovine Lactoferrin Using Pectin- and Chitosan-Modified Liposomes and Solid Lipid Particles: Improvement of Stability of Lactoferrin

Chemical Biology and Drug Design

Volumn 86, Issue 4, 2015, Pages 466-475

  Yao, Xudong ^a   Bunt, Craig ^b   Cornish, Jillian ^c   Quek, Siew Young ^a   Wen, Jingyuan ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b LINCOLN UNIVERSITY   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Drug Delivery ADMET; Nanotechnology (Drug Discovery); Protein Structure

Indexed keywords

BOVINE LACTOFERRIN; CHITOSAN; LACTOFERRIN; LIPOSOME; PECTIN; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG CONFORMATION; DRUG RELEASE; DRUG STABILITY; ENVIRONMENTAL FACTOR; ENZYMATIC DEGRADATION; HEAT TOLERANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE; HYDRODYNAMICS; INTESTINE FLUID; IONIC STRENGTH; LIPOLYSIS; MOLECULAR WEIGHT; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STORAGE TEMPERATURE; SURFACE CHARGE; SURFACE PROPERTY; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; BOVINE; CHEMISTRY; ORAL DRUG ADMINISTRATION; PROTEIN STABILITY;

ADMINISTRATION, ORAL; ANIMALS; CATTLE; CHITOSAN; LACTOFERRIN; LIPOSOMES; PECTINS; PROTEIN STABILITY;

EID: 84942434510     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12509     Document Type: Article

References (67)

1. Soerensen M., Soerensen S.P.L., (1939) The protein in whey. C R Trav Lab Carlsberg; 23: 55-99.
2. Schryvers A.B., Morris L.J., (1988) Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis. Infect Immun; 56: 1144-1149.
3. Ellison R.T., Giehl T.J., (1991) Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest; 88: 1080-1091.
4. Takakura N., Wakabayashi H., Ishibashi H., Teraguchi S., Tamura Y., Yamaguchi H., Abe S., (2003) Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob Agents Chemother; 47: 2619-2623.
5. Marchetti M., Superti F., Ammendolia M.G., Rossi P., Valenti P., Seganti L., (1999) Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin. Med Microbiol Immunol; 187: 199-204.
6. Murphy M.E., Kariwa H., Mizutani T., Tanabe H., Yoshimatsu K., Arikawa J., Takashima I., (2001) Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus. J Vet Med Sci; 63: 637-645.
7. Berkhout B., Floris R., Recio I., Visser S., (2004) The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1. Biometals; 17: 291-294.
8. Eliassen L.T., Berge G., Sveinbjornsson B., Svendsen J.S., Vorland L.H., Rekdal O., (2002) Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Res; 22: 2703-2710.
9. Tsuda H., Sekine K., Fujita K., Iigo M., (2002) Cancer prevention by bovine lactoferrin and underlying mechanisms-a review of experimental and clinical studies. Biochem Cell Biol; 80: 131-136.
10. Appelmelk B.J., An Y.Q., Geerts M., Thijs B.G., de Boer H.A., MacLaren D.M., de Graaff J., Nuijens J.H., (1994) Lactoferrin is a lipid A-binding protein. Infect Immun; 62: 2628-2632.
11. Hayashida K., Kaneko T., Takeuchi T., Shimizu H., Ando K., Harada E., (2004) Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J Vet Med Sci; 66: 149-154.
12. Cornish J., Palmano K., Callon K.E., Watson M., Lin J.M., Valenti P., Naot D., Grey A.B., Reid I.R., (2006) Lactoferrin and bone: structure-activity relationships. Biochem Cell Biol; 84: 297-302.
13. Cornish J., Callon K.E., Naot D., Palmano K., Banovic T., Bava U., Watson M., et al., (2004) Lactoferrin is a potent regular of bone cell activity and increases bone formation in vivo. Endocrinology; 145: 4366-4374.
14. Grey A., Zhu Q., Watson M., Callon K., Cornish J., (2006) Lactoferrin potently inhibits osteoblast apoptosis, via an LRP-1-independent pathway. Mol Cell Endocrinol; 251: 96-102.
15. Tomita M., Wakabayashi H., Yamauchi K., Teraguchi S., Hayasawa H., (2002) Bovine lactoferrin and lactoferricin derived from milk: production and application. Biochem Cell Biol; 80: 109-112.
16. Teraguchi S., Wakabayashi H., Kuwata H., Yamauchi K., Tamura Y., (2004) Protection against infection by oral lactoferrin: evaluation in animal model. Biometals; 17: 231-234.
17. Bernkop-Schnurch A., Clausen A., (2002) Biomembrane permeability of peptides: strategies to improve their mucosal uptake. Mini Rev Med Chem; 2: 295-305.
18. Troost F.J., Saris W.H.M., Brummer R.J.M., (2002) Orally ingested human lactoferrin is digested and secreted in the upper gastrointestinal tract in vivo in women with ileostomies. J Nutr; 132: 2597-2600.
19. Watnasirichaikul S., Davies N.M., Rades T., Tucker I.G., (2000) Preparation of biodegradable insulin nanocapsules from biocompatible microemulsion. Pharm Res; 17: 684-689.
20. Liu W., Ye A., Liu W., Liu C., Singh H., (2013) Stability during in vitro digestion of lactoferrin-loaded liposomes prepared from milk fat globule membrane-derived phospholipids. J Dairy Sci; 96: 2061-2070.
21. Ma J., Guan R., Shen H., Lu F., Xiao C., Liu M., Kang T., (2013) Comparison of anticancer activity between lactoferrin nanoliposome and lactoferrin in Caco-2 cells in vitro. Food Chem Toxicol; 59: 72-77.
22. David-Birman T., Mackie A., Lesmes U., (2013) Impact of dietary fibers on the properties and proteolytic digestibility of lactoferrin nano-particles. Food Hydrocoll; 31: 33-41.
23. Balcao V.M., Costa C.I., Matos C.M., Moutinho C.G., Amorim M., Pintado M.E., Gomes A.P., Vila M.M., Teixeira J.A., (2013) Nanoencapsulation of bovine lactoferrin for food and biopharmaceutical applications. Food Hydrocoll; 32: 425-431.
24. Yao X., Bunt C., Cornish J., Quek S.Y., Wen J., (2014) Preparation, optimization and characterization of bovine lactoferrin-loaded liposomes and solid lipid particles modified by hydrophilic polymers using factorial design. Chem Biol Drug Des; 83: 560-575.
25. Li N., Zhuang C., Wang M., Sun X., Nie S., Pan W., (2009) Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm; 379: 131-138.
26. Ngugen S., Alund S.J., Hiorth M., Kjoniksen A., Smistad G., (2011) Studies on pectin coating of liposomes for drug delivery. Colloids Surf B Biointerfaces; 88: 664-673.
27. Venishetty V.K., Chede R., Komuravelli R., Adepu L., Sistla R., Diwan P.V., (2012) Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids Surf B Biointerfaces; 95: 1-9.
28. Heurtault B., Saulnier P., Pech B., Proust J., Benoit J., (2003) Physico-chemical stability of colloidal lipid particles. Biomaterials; 24: 4283-4300.
29. Choi K.O., Aditya N.P., Ko S., (2014) Effect of aqueous pH and electrolyte concentration on structure, stability and flow behavior of non-ionic surfactant based solid lipid nanoparticles. Food Chem; 147: 239-244.
30. Yao X., Bunt C., Cornish J., Quek S.Y., Wen J., (2013) Improved RP-HPLC method for determination of bovine lactoferrin and its proteolytic degradation in simulated gastrointestinal fluids. Biomed Chromatogr; 27: 197-202.
31. Hu M., Li Y., Decker E.A., McClements D.J., (2010) Role of calcium and calcium-binding agents on the lipase digestibility of emulsified lipid using an in vitro digestion model. Food Hydrocoll; 24: 710-725.
32. Sharma A., Sharma U.S., (1997) Liposomes in drug delivery: progress ad limitations. Int J Pharm; 154: 123-140.
33. Sulkowski W.W., Pentak D., Nowak K., Sulkowska A., (2005) The influence of temperature, cholesterol content and pH on liposome stability. J Mol Struct; 744-747: 737-747.
34. Aditya N.P., Shim M., Lee I., Lee Y., Im M.-H., Ko S., (2013) Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. J Agr Food Chem; 61: 1878-1883.
35. Wei C.C., Ge Z.Q., (2012) Influence of electrolyte and poloxamer 188 on the aggregation kinetics of solid lipid nanoparticles (SLNs). Drug Dev Ind Pharm; 38: 1084-1089.
36. Freitas C., Muller R.H., (1999) Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte. J Microencapsul; 16: 59-71.
37. Janiak M.J., Small D.M., Shipley G.G., (1976) Nature of thermal pre-transition of synthetic phospholipids-dimyristoyllecithin and dipalmitoyllecithin. Biochemistry; 15: 4575-4580.
38. Grit M., Desmidt J.H., Struijke A., Crommelin D.J.A., (1989) Hydrolysis of phosphatidylcholine in aqueous liposome dispersions. Int J Pharm; 50: 1-6.
39. Kikuchi H., Carlsson A., Yachi K., Hirota S., (1991) Possibility of heat sterilization of liposomes. Chem Pharm Bull; 39: 1018-1022.
40. Han H.K., Shin H.J., Ha D.H., (2012) Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Eur J Pharm Sci; 46: 500-507.
41. Gradauer K., Barthelmes J., Vonach C., Almer G., Mangge H., Teubl B., Roblegg E., Dunnhaupt S., Frohlich E., Bernkop-Schnurch A., Prassl R., (2013) Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. J Control Release; 172: 872-878.
42. Li Y., Zhao H., Duan L.R., Li H., Yang Q., Tu H.H., Cao W., Wang S.W., (2014) Preparation, characterization and evaluation of bufalin liposomes coated with citrus pectin. Colloids Surf A Physicochem Eng Asp; 444: 54-62.
43. Volodkin D., Mohwald H., Voegel J.C., Ball V., (2007) Coating of negatively charged liposomes by polylysine: drug release study. J Control Release; 117: 111-120.
44. Smistad G., Boyum S., Alund S.J., Samuelsen A.B.C., Hiorth M., (2012) The potential of pectin as a stabilizer for liposomal drug delivery systems. Carbohydr Polym; 90: 1337-1344.
45. Samuni A.M., Lipman A., Barenholz Y., (2000) Damage to liposomal lipids: protection by antioxidants and cholesterol-mediated dehydration. Chem Phys Lipids; 105: 121-134.
46. Notter R.H., Smith S., Taubold R.D., Finkelstein J.N., (1982) Path dependence of adsorption behaviour of mixtures containing dipalmitoyl phosphatidylcholine. Pediatr Res; 16: 515-519.
47. Storm G., Roerdink F.H., Steerenberg P.A., de Jong W.H., Crommelin D.J., (1987) Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res; 47: 3366-3372.
48. Simon S.A., McIntosh T.J., (1986) Depth of water penetration into lipid bilayers. Methods Enzymol; 127: 511-521.
49. Schiffter H.A., (2011) Pharmaceutical proteins-Structure, Stability, and formulation. In:, Moo-Young M., editor. Comprehensive Biotechnology. Oxford, UK: Elsevier; p. 521-541.
50. Xie S., Zhu L., Dong Z., Wang X., Wang Y., Li X., Zhou W., (2011) Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid particles: influences of fatty acids. Colloids Surf B Biointerfaces; 83: 382-387.
51. Zhang Q., Yie G., Li Y., Yang Q., Nagai T., (2000) Studies on the cyclosporine A loaded stearic acid nanoparticles. Int J Pharm; 200: 153-159.
52. Mehnert W., Mader K., (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev; 47: 165-196.
53. Jin A.J., Huster D., Gawrisch K., Nossal R., (1999) Light scattering characterization of extruded lipid vesicles. Eur Biophys J; 28: 187-199.
54. Douaihy C.M., Koka V., Mingotaud C., Gauffre F., (2006) Tunable sustained release properties of "onion-like" phospholipids multilamellar vesicles. J Colloid Interface Sci; 303: 280-287.
55. Li H., Zhao X., Ma Y., Zhai G., Li L., Lou H., (2009) Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release; 133: 238-244.
56. Dhawa S., Kapil R., Singh B., (2011) Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. J Pharm Pharmacol; 63: 342-351.
57. Bose S., Du Y., Takhistov P., Michniak-Kohn B., (2013) Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. Int J Pharm; 441: 56-66.
58. Hayat M.A., (2000) Principles and Techniques of Electron Microscopy, Biological Applications, 4th edn. Cambridge, UK: Cambridge University Press; p. 372-374.
59. Zangenberg N.H., Mullertz A., Kristensen H.G., Hovgaard L., (2001) A dynamic in vitro lipolysis model. II: evaluation of the model. Eur J Pharm Sci; 14: 237-244.
60. Zangenberg N.H., Mullertz A., Kristensen H.G., Hovgaard L., (2001) A dynamic in vitro lipolysis model. I: controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci; 14: 115-122.
61. Nishizuka Y., (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science; 258: 607-614.
62. Howles P.N., Carter C.P., Hui D.Y., (1996) Dietary free and esterified cholesterol absorption in cholesterol esterase (bile salt-stimulated lipase) gene-targeted mice. J Biol Chem; 271: 7196-7202.
63. Carey M.C., Small D., Bliss C., (1983) Lipid digestion and absorption. Annu Rev Physiol; 45: 651-677.
64. Liu W., Ye A., Liu C., Liu W., Singh H., (2012) Structure and integrity of liposomes prepared from milk- or soybean-derived phospholipids during in vitro digestion. Food Res Int; 48: 499-506.
65. Kokkona M., Kallinteri P., Fatouros D., Antimisiaris S.G., (2000) Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. Eur J Pharm Sci; 9: 245-252.
66. Hu M., Li Y., Decker E.A., Xiao H., McClements D.J., (2010) Influence of tripolyphosphate cross-linking on the physical stability and lipase digestibility of chitosan-coated lipid droplets. J Agric Food Chem; 58: 1283-1289.
67. McClements D.J., (2010) Design of nano-laminated coatings to control bioavailability of lipophilic food components. J Food Sci; 75: 30-42.